NeuroBo Pharmaceuticals, Inc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NRBO and buy or sell other stocks, ETFs, and their options commission-free!About NRBO
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
CEOHyung-Heon Kim
CEOHyung-Heon Kim
Employees9
Employees9
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2014
Founded2014
Employees9
Employees9
NRBO Key Statistics
Market cap116.15M
Market cap116.15M
Price-Earnings ratio-0.21
Price-Earnings ratio-0.21
Dividend yield—
Dividend yield—
Average volume182.01K
Average volume182.01K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.30
52 Week high$5.30
52 Week low$0.647
52 Week low$0.647
People also own
Based on the portfolios of people who own NRBO. This list is generated using Robinhood data, and it’s not a recommendation.